Neera K Goyal1, Jessica F Rohde2,3, Vanessa Short4, Stephen W Patrick5, Diane Abatemarco4, Esther K Chung6. 1. Departments of Pediatrics and neera.goyal@nemours.org. 2. Departments of Pediatrics and. 3. Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware. 4. Obstetrics and Gynecology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. 5. Division of Neonatology, Departments of Pediatrics and Health Policy and Vanderbilt Center for Child Health Policy, School of Medicine, Vanderbilt University, Nashville, Tennessee; and. 6. Department of Pediatrics, School of Medicine, University of Washington and Seattle Children's Hospital, Seattle, Washington.
Abstract
BACKGROUND AND OBJECTIVES: For children with intrauterine opioid exposure (IOE), well-child care (WCC) provides an important opportunity to address medical, developmental, and psychosocial needs. We evaluated WCC adherence for this population. METHODS: In this retrospective cohort study, we used PEDSnet data from a pediatric primary care network spanning 3 states from 2011 to 2016. IOE was ascertained by using physician diagnosis codes. WCC adherence in the first year was defined as a postnatal or 1-month visit and completed 2-, 4-, 6-, 9-, and 12-month visits. WCC adherence in the second year was defined as completed 15- and 18-month visits. Gaps in WCC, defined as ≥2 missed consecutive WCC visits, were also evaluated. We used multivariable regression to test the independent effect of IOE status. RESULTS: Among 11 334 children, 236 (2.1%) had a diagnosis of IOE. Children with IOE had a median of 6 WCC visits (interquartile range 5-7), vs 8 (interquartile range 6-8) among children who were not exposed (P < .001). IOE was associated with decreased WCC adherence over the first and second years of life (adjusted relative risk 0.54 [P < .001] and 0.74 [P < .001]). WCC gaps were more likely in this population (adjusted relative risk 1.43; P < .001). There were no significant adjusted differences in nonroutine primary care visits, immunizations by age 2, or lead screening. CONCLUSIONS: Children <2 years of age with IOE are less likely to adhere to recommended WCC, despite receiving on-time immunizations and lead screening. Further research should be focused on the role of WCC visits to support the complex needs of this population.
BACKGROUND AND OBJECTIVES: For children with intrauterine opioid exposure (IOE), well-child care (WCC) provides an important opportunity to address medical, developmental, and psychosocial needs. We evaluated WCC adherence for this population. METHODS: In this retrospective cohort study, we used PEDSnet data from a pediatric primary care network spanning 3 states from 2011 to 2016. IOE was ascertained by using physician diagnosis codes. WCC adherence in the first year was defined as a postnatal or 1-month visit and completed 2-, 4-, 6-, 9-, and 12-month visits. WCC adherence in the second year was defined as completed 15- and 18-month visits. Gaps in WCC, defined as ≥2 missed consecutive WCC visits, were also evaluated. We used multivariable regression to test the independent effect of IOE status. RESULTS: Among 11 334 children, 236 (2.1%) had a diagnosis of IOE. Children with IOE had a median of 6 WCC visits (interquartile range 5-7), vs 8 (interquartile range 6-8) among children who were not exposed (P < .001). IOE was associated with decreased WCC adherence over the first and second years of life (adjusted relative risk 0.54 [P < .001] and 0.74 [P < .001]). WCC gaps were more likely in this population (adjusted relative risk 1.43; P < .001). There were no significant adjusted differences in nonroutine primary care visits, immunizations by age 2, or lead screening. CONCLUSIONS:Children <2 years of age with IOE are less likely to adhere to recommended WCC, despite receiving on-time immunizations and lead screening. Further research should be focused on the role of WCC visits to support the complex needs of this population.
Authors: Elizabeth O'Connor; Rebecca C Rossom; Michelle Henninger; Holly C Groom; Brittany U Burda Journal: JAMA Date: 2016-01-26 Impact factor: 56.272
Authors: Elizabeth R Wolf; Camille J Hochheimer; Roy T Sabo; Jennifer DeVoe; Richard Wasserman; Erik Geissal; Douglas J Opel; Nate Warren; Jon Puro; Jennifer O'Neil; James Pecsok; Alex H Krist Journal: Pediatrics Date: 2018-10-10 Impact factor: 7.124
Authors: Stephanie L Merhar; Jennifer M McAllister; Kathryn E Wedig-Stevie; Amy C Klein; Jareen Meinzen-Derr; Brenda B Poindexter Journal: J Perinatol Date: 2018-03-07 Impact factor: 2.521
Authors: Kristen L Benninger; Celine Richard; Sara Conroy; Julia Newton; H Gerry Taylor; Alaisha Sayed; Lindsay Pietruszewski; Mary Ann Nelin; Nancy Batterson; Nathalie L Maitre Journal: Perspect ASHA Spec Interest Groups Date: 2022-06-27
Authors: Jean Y Ko; Jangho Yoon; Van T Tong; Sarah C Haight; Roshni Patel; Karilynn M Rockhill; Jeff Luck; Carrie Shapiro-Mendoza Journal: Drug Alcohol Depend Date: 2021-04-20 Impact factor: 4.852